Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas

Molecular Endocrinology

Volumn 24, Issue 12, 2010, Pages 2382-2391

  López Jiménez, Elena ^a   Gómez López, Gonzalo ^a   Leandro García, L Javier ^a   Muñoz, Iván ^a   Schiavi, Francesca ^b   Montero Conde, Cristina ^a   De Cubas, Aguirre A ^a   Ramires, Ricardo ^a   Landa, Iñigo ^a   Leskelä, Susanna ^a   Maliszewska, Agnieszka ^a   Inglada Pérez, Lucía ^a   De La Vega, Leticia ^a   Rodríguez Antona, Cristina ^a,c   Letón, Rocío ^a   Bernal, Carmen ^a   De Campos, José M ^e   Diez Tascón, Cristina ^f   Fraga, Mario F ^g   Boullosa, Cesar ^d   Pisano, David G ^a   Opocher, Giuseppe ^b,h   Robledo, Mercedes ^a,c   Cascón, Alberto ^a,c   more..

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^f Complejo Asistencial Universitario de León   (Spain)

^g CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^h UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; NEUROFIBROMIN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL HYDROXYLASE 3; PROTEIN RET; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE B; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; GENE ACTIVATION; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DEATH; CHILD; DIOXYGENASES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MIDDLE AGED; NEOPLASMS; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SUCCINATE DEHYDROGENASE; VON HIPPEL-LINDAU DISEASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN; YOUNG ADULT;

EID: 78649404935     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0256     Document Type: Article

References (44)

1. Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, Kunst H, Devilee P, Cremers CW, Schiffman JD, Bentz BG, Gygi SP, Winge DR, Kremer H, Rutter J 2009 SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325:1139-1142
2. Burnichon N, Brière JJ, Libé R, Vescovo L, Rivière J, Tissier F, Jouanno E, Jeunemaitre X, Bénit P, Tzagoloff A, Rustin P, Bertherat J, Favier J, Gimenez-Roqueplo AP 2010 SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 19:3011-3020
3. Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, Chocron ES, Lechleiter JD, Sass M, Aronin N, Schiavi F, Boaretto F, Opocher G, Toledo RA, Toledo SP, Stiles C, Aguiar RC, Dahia PL 2010 Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 42:229-233
4. Lee S, Nakamura E, Yang H, Wei W, Linggi MS, Sajan MP, Farese RV, Freeman RS, Carter BD, Kaelin Jr WG, Schlisio S 2005 Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8:155-167
5. Schlisio S, Kenchappa RS, Vredeveld LC, George RE, Stewart R, Greulich H, Shahriari K, Nguyen NV, Pigny P, Dahia PL, Pomeroy SL, Maris JM, Look AT, Meyerson M, Peeper DS, Carter BD, Kaelin Jr WG 2008 The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev 22:884-893
6. Dahia PL, Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS, Hodin R, Heitritter S, Moore F, Dluhy R, Sosa JA, Ocal IT, Benn DE, Marsh DJ, Robinson BG, Schneider K, Garber J, Arum SM, Korbonits M, Grossman A, Pigny P, Toledo SP, Nosé V, Li C, Stiles CD 2005 A HIF1α regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 1:72-80
7. Eisenhofer G, Huynh TT, Pacak K, Brouwers FM, Walther MM, Linehan WM, Munson PJ, Mannelli M, Goldstein DS, Elkahloun AG 2004 Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. Endocr Relat Cancer 11:897-911 (Pubitemid 40065561)
8. Favier J, Brière JJ, Burnichon N, Rivière J, Vescovo L, Benit P, Giscos-Douriez I, De Reyniès A, Bertherat J, Badoual C, Tissier F, Amar L, Libé R, Plouin PF, Jeunemaitre X, Rustin P, Gimenez-Roqueplo AP 2009 The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS One 4:e7094
9. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, Khau Van Kien P, Corvol P, Plouin PF, Jeunemaitre X 2003 Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 63:5615-5621
10. Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM, Pacak K 2006 High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J Clin Endocrinol Metab 91:4505-4509
11. Adjallé R, Plouin PF, Pacak K, Lehnert H 2009 Treatment of malignant pheochromocytoma. Horm Metab Res 41:687-696
12. Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ 2005 Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 25:5675-5686 (Pubitemid 40853601)
13. Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A 2001 Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem 276:9519-9525
14. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U, Bondesson M 2005 Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9:617-628
15. Maranchie JK, Zhan Y 2005 Nox4 is critical for hypoxia-inducible factor 2-α transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma. Cancer Res 65:9190-9193 (Pubitemid 41507983)
16. Pollard PJ, El-Bahrawy M, Poulsom R, Elia G, Killick P, Kelly G, Hunt T, Jeffery R, Seedhar P, Barwell J, Latif F, Gleeson MJ, Hodgson SV, Stamp GW, Tomlinson IP, Maher ER 2006 Expression of HIF-1α, HIF-2α (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations. J Clin Endocrinol Metab 91:4593-4598
17. Cervera AM, Apostolova N, Crespo FL, Mata M, McCreath KJ 2008 Cells silenced for SDHB expression display characteristic features of the tumor phenotype. Cancer Res 68:4058-4067
18. Lee CM, Hickey MM, Sanford CA, McGuire CG, Cowey CL, Simon MC, Rathmell WK 2009 VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo. Oncogene 28:1694-1705
19. Aprelikova O, Chandramouli GV, Wood M, Vasselli JR, Riss J, Maranchie JK, Linehan WM, Barrett JC 2004 Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J Cell Biochem 92:491-501
20. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim Av, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ 2001 Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472
21. 2 sensing and cancer. Nat Rev Cancer 8:865-873
22. Berra E, Benizri E, Ginouvès A, Volmat V, Roux D, Pouysségur J 2003 HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J 22:4082-4090 (Pubitemid 37021737)
23. Fu J, Menzies K, Freeman RS, Taubman MB 2007 EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability. J Biol Chem 282:12410-12418
24. Fu J, Taubman MB 2010 Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-κB-dependent pathway. J Biol Chem 285:8927-8935
25. Xue J, Li X, Jiao S, Wei Y, Wu G, Fang J 2010 Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKβ independent of hydroxylase activity. Gastroenterology 138:606-615
26. Sato E, Torigoe T, Hirohashi Y, Kitamura H, Tanaka T, Honma I, Asanuma H, Harada K, Takasu H, Masumori N, Ito N, Hasegawa T, Tsukamoto T, Sato N 2008 Identification of an immunogenic CTL epitope of HIFPH3 for immunotherapy of renal cell carcinoma. Clin Cancer Res 14:6916-6923
27. Steenhard BM, Isom K, Stroganova L, St John PL, Zelenchuk A, Freeburg PB, Holzman LB, Abrahamson DR 2010 Deletion of Von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen α1α2α1(IV), expression of neuroglobin, and proteinuria. Am J Pathol 177:84-96
28. Hatzimichael E, Dasoula A, Shah R, Syed N, Papoudou-Bai A, Coley HM, Dranitsaris G, Bourantas KL, Stebbing J, Crook T 2010 The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia. Eur J Haematol 84:47-51
29. Kothari S, Cizeau J, McMillan-Ward E, Israels SJ, Bailes M, Ens K, Kirshenbaum LA, Gibson SB 2003 BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 22:4734-4744
30. Fei P, Wang W, Kim SH, Wang S, Burns TF, Sax JK, Buzzai M, Dicker DT, McKenna WG, Bernhard EJ, El-Deiry WS 2004 Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. Cancer Cell 6:597-609 (Pubitemid 40017703)
31. Kaelin Jr WG 2009 SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling. Cancer Cell 16:180-182
32. Tracy K, Dibling BC, Spike BT, Knabb JR, Schumacker P, Macleod KF 2007 BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol 27:6229-6242
33. Cascon A, Pita G, Burnichon N, Landa I, Lopez-Jimenez E, Montero-Conde C, Leskela S, Leandro-Garcia LJ, Leton R, Rodriguez-Antona C, Diaz JA, Lopez-Vidriero E, Gonzalez-Neira A, Velasco A, Matias-Guiu X, Gimenez-Roqueplo AP, Robledo M 2009 Genetics of pheochromocytoma and paraganglioma in Spanish patients. J Clin Endocrinol Metab 94:2677-2683
34. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A, Smyth GK 2007 A comparison of background correction methods for two-colour microarrays. Bioinformatics 23:2700-2707
35. Smyth GK, Michaud J, Scott HS 2005 Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21:2067-2075 (Pubitemid 40668046)
36. Montaner D, Tárraga J, Huerta-Cepas J, Burguet J, Vaquerizas JM, Conde L, Minguez P, Vera J, Mukherjee S, Valls J, Pujana MA, Alloza E, Herrero J, Al-Shahrour F, Dopazo J 2006 Next station in microarray data analysis: GEPAS. Nucleic Acids Res 34:W486-W491
37. Reich M, Ohm K, Angelo M, Tamayo P, Mesirov JP 2004 Gene-Cluster 2.0: an advanced toolset for bioarray analysis. Bioinformatics 20:1797-1798
38. Monti S, Tamayo P, Mesirov J, Golub T 2003 Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach Learn 52:91-118
39. Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC, Xavier RJ 2009 An integrative genomics approach identifies hypoxia inducible factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res 37:4587-4602
40. Morrissey ER, Diaz-Uriarte R 2009 Pomelo II: finding differentially expressed genes. Nucleic Acids Res 37(Suppl 2): W581-W586
41. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I 2001 Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125:279-284 (Pubitemid 33000466)
42. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545-15550
43. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB 1996 Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826
44. Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB, Herman JG 2000 Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 60:4366-4371 (Pubitemid 32103613)